Global Serine Protein Kinase ATM Market Outlook: Ken Research Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) pipeline Target constitutes close to 6 molecules. Out of which approximately 5 molecules are developed by companies and remaining by the universities/institutes. The latest report Serine Protein Kinase ATM – Pipeline Review, H1 2018, outlays comprehensive information on the Serine Protein Kinase ATM… Read More »
